---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-011246"
form_type: "8-K"
ticker: "FEED"
cik: "0001326706"
company_name: "ENvue Medical, Inc."
filed_at: "2025-05-16T23:59:59+00:00"
generated_at: "2026-05-21T02:55:33.519229+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# NanoVibronix raises $10M in public offering of Series G preferred and warrants

## Summary
- Gross proceeds ~$10M from 400,000 Series G convertible preferred shares at $25/share, each with a warrant to buy 4.9M common shares at $2.04.
- Preferred pays 9% cumulative dividend, convertible at $2.04/share, subject to full-ratchet anti-dilution and 4.99%/9.99% beneficial ownership cap.
- Use of proceeds: repay $1.3M debenture (Feb 2025) and up to $700k on $2.5M note (Jan 2025); remainder for general corporate purposes.
- Amended Series X preferred: increased authorized shares from 57,720 to 62,220 and cut conversion price to match Series G price.
- Dawson James Securities acted as sole bookrunner; offering closed May 16, 2025.

## SEC filing metadata
- accession: 0001641172-25-011246
- form_type: 8-K
- ticker: FEED
- cik: 0001326706
- company_name: ENvue Medical, Inc.
- filed_at: 2025-05-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.03, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326706/000164117225011246/0001641172-25-011246-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326706/000164117225011246/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-011246
- JSON: https://secwatch.observer/filing/0001641172-25-011246.json
- Plain text: https://secwatch.observer/filing/0001641172-25-011246.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.